Longspur International Ventures Ltd vs Prism Medico Pharmacy Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Longspur International Ventures Ltd is ₹ 8.01 as of 30 Oct 15:30 . The P/E Ratio of Longspur International Ventures Ltd changed from 252.5 on March 2022 to 14.8 on March 2026 . This represents a CAGR of -43.30% over 5 yearsThe P/E Ratio of Prism Medico & Pharmacy Ltd changed from 47.6 on March 2026 to 47.6 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Longspur International Ventures Ltd changed from ₹ 5.07 crore on March 2021 to ₹ 7.89 crore on March 2026 . This represents a CAGR of 7.65% over 6 yearsThe Market Cap of Prism Medico & Pharmacy Ltd changed from ₹ 7.06 crore on March 2021 to ₹ 15.29 crore on March 2026 . This represents a CAGR of 13.75% over 6 years The revenue of Longspur International Ventures Ltd for the Jun '26 is ₹ 0.75 crore as compare to the Mar '26 revenue of ₹ 1.48 crore. This represent the decline of -49.32% The revenue of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0.09 crore as compare to the Mar '26 revenue of ₹ 0.28 crore. This represent the decline of -67.86% The ebitda of Longspur International Ventures Ltd for the Jun '26 is ₹ 0.3 crore as compare to the Mar '26 ebitda of ₹ -0.04 crore. This represent the decline of -850% The ebitda of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the decline of -50% The net profit of Longspur International Ventures Ltd changed from ₹ 0.14 crore to ₹ 0.16 crore over 9 quarters. This represents a CAGR of 6.11% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ -0.09 crore to ₹ -0.06 crore over 9 quarters. This represents a CAGR of -16.49% The Dividend Payout of Longspur International Ventures Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Longspur International Ventures Ltd

Longspur International Ventures Limited was originally incorporated as Public Limited Company in the name of 'Confidence Trading Company Limited' on 16 September, 1980.
Subsequently, the name of Company was changed to Confidence Finance and Trading Limited on 24th February, 2014 and thereafter to Longspur International Ventures Limited on 18 January, 2024.
Presently, Company is carrying out business of financial service and trading. In 2010, Mr. Suresh Kumar Somani acquired 36500 Equity Shares of the Company through Share Purchase Agreement entered with Ms. Sridevi Chimalamarri, the erstwhile Promoter of the Company on June 24, 2009 aggregating to 73% of the Paid Up Capital of the Company.
Resulting this, the open offer process was completed and Mr. Suresh Kumar Somani took the control over the Company effective from November 23, 2009.

About Prism Medico & Pharmacy Ltd

Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities. Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading. During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.

FAQs for the comparison of Longspur International Ventures Ltd and Prism Medico & Pharmacy Ltd

Which company has a larger market capitalization, Longspur International Ventures Ltd or Prism Medico & Pharmacy Ltd?

Market cap of Longspur International Ventures Ltd is 24 Cr while Market cap of Prism Medico & Pharmacy Ltd is 47 Cr

What are the key factors driving the stock performance of Longspur International Ventures Ltd and Prism Medico & Pharmacy Ltd?

The stock performance of Longspur International Ventures Ltd and Prism Medico & Pharmacy Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Longspur International Ventures Ltd and Prism Medico & Pharmacy Ltd?

As of October 31, 2026, the Longspur International Ventures Ltd stock price is INR ₹8.01. On the other hand, Prism Medico & Pharmacy Ltd stock price is INR ₹35.05.

How do dividend payouts of Longspur International Ventures Ltd and Prism Medico & Pharmacy Ltd compare?

To compare the dividend payouts of Longspur International Ventures Ltd and Prism Medico & Pharmacy Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.